COLLABORATION AGREEMENT AND LICENSE OPTIONCollaboration Agreement and License Option • March 31st, 2014 • Capricor Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Collaboration Agreement and License Option (this “Agreement”), dated as of December 27, 2013 (the “Effective Date”), is made by and between Capricor, Inc., a Delaware corporation, having its principal place of business at 8840 Wilshire Boulevard, 2nd Floor, Beverly Hills, California 90211 (“Capricor”), and Janssen Biotech, Inc., a Pennsylvania corporation, and having an office at 800/850 Ridgeview Drive, Horsham, Pennsylvania 19044 (“JBI”). Capricor and JBI are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
